Premenstrual SyndromeNCT07737366
The Efficacy of Lavender Herbal Tea in Premenstrual Syndrome
A study testing Lavender herbal tea in people with Premenstrual Syndrome and Anxiety, run by Sakarya University at 1 site in Turkey (Türkiye).
Trial summary
Premenstrual syndrome (PMS) is a common but complex condition defined as a combination of emotional, psychological, and physical symptoms that occur during the luteal phase of the menstrual cycle, usually between 2 and 14 days before the onset of menstruation, and that diminish with menstruation. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Premenstrual Syndrome, Anxiety, Depression
- What is being tested?
- Lavender herbal tea
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 9 Jul 2025to 18 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- No history of acute or chronic illness, Meeting the diagnostic criteria for PMS specified by ACOG, Over 18 years of age, No psychiatric distress and no treatment for psychiatric distress in the last 3 months, No (current or past) participation in psychotherapy for premenstrual symptoms, Not pregnant, Gynecological diseases (hysterectomy, oophorectomy, gynecological cancer, polycystic ovary syndrome, endometriosis, infertility) are among the inclusion criteria.
Who cannot join
- Allergy to any herbal tea, food or medicine, Psychiatric illness or chronic illness, Use of psychiatric medication (such as anxiolytics and antidepressants), Regular medication use (such as antihypertensive, antidiabetic), Regular use of herbal teas or complementary medicines, Failure to meet the diagnostic criteria for PMS specified by ACOG, No regular menstruation in the last 3 months, Use of oral contraceptives during the last 3 months, Use of analgesics during menstruation while participating in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Psychological and Physiological Effects of Lavender Herbal Tea in Women With Premenstrual Syndrome: a Randomized Clinical Trial
Premenstrual syndrome (PMS) is a common but complex condition defined as a combination of emotional, psychological, and physical symptoms that occur during the luteal phase of the menstrual cycle, usually between 2 and 14 days before the onset of menstruation, and that diminish with menstruation. Epidemiological studies have reported that 80-90% of women experience premenstrual syndrome symptoms, with approximately 20-40% reported to affect daily functioning and relationships. Symptoms associated with PMS include irritability, mood swings, anxiety, depression, bloating, breast tenderness, and headaches. Pharmacological treatments such as selective serotonin reuptake inhibitors (SSRIs) and non-pharmacological methods such as dietary changes, exercise, and cognitive behavioral therapy are used in the management of PMS symptoms. Complementary herbal therapies are gaining increasing interest among individuals who want to avoid the side effects of traditional pharmacological agents. Various agents such as Vitex agnus-castus (chaste tree), Hypericum perforatum (St John's wort), evening primrose oil, and conventional herbal formulations have been studied in the literature. Vitex agnus-castus was found to be effective in relieving PMS symptoms by regulating hormonal balance. The antidepressant effects of yellow cantharone have been evaluated, but findings on its efficacy are inconsistent. Evening primrose oil shows particularly favorable effects on cyclic mastalgia. Lavender tea is known to reduce depression, anxiety, and mood swings. There are no clinical studies evaluating the effect of lavender tea on menstrual bleeding. A randomized controlled trial has shown that abdominal massage with lavender oil reduces the severity of menstrual pain. In this context, it may be a potential complementary herbal treatment to relieve PMS symptoms. Therefore, women with PMS will be divided into two groups. The intervention group will use 2 grams of lavender tea 2 times a day, morning and evening, for 9 days during 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). The control group will create a waiting list. The study data will be provided by 'Personal Information Form', 'Premenstrual Syndrome Scale', 'Depression Anxiety Stress-21 Scale', 'Premenstrual Syndrome Specific Quality of Life Scale', Visual Analogue Scale (VAS), and pad follow-up to monitor bleeding. SPSS 25.0 software will be used to analyze the data obtained from the study. Although the effects of lavender tea on PMS are promising, more clinical studies are needed to confirm its effectiveness. With this study, the need for clinical studies on the effectiveness of lavender tea will be met and a natural and complementary treatment method that can alleviate PMS symptoms will be tested.
Read the detailed description
Premenstrual syndrome (PMS) is a clinical picture characterized by physical, psychological, and behavioral symptoms that occur during the luteal phase of the menstrual cycle, starting approximately one week before menstruation and decreasing with menstruation. The prevalence of PMS is quite high and it is reported that 50-90% of women experience at least one PMS symptom during the reproductive age. Physical symptoms of PMS include breast tenderness and bloating, headaches, muscle and joint pain, fatigue, appetite changes, sleep disturbances, and skin problems. Psychological symptoms include irritability, outbursts of anger, hypersensitivity, crying spells, difficulty focusing, and social isolation. Behavioral symptoms include overeating, increased alcohol and caffeine consumption, sleep irregularity, and decreased physical activity.
Pharmacological, non-pharmacological, and complementary approaches are applied in the management of PMS symptoms. Within the scope of pharmacological treatment, Selective Serotonin Reuptake Inhibitors (SSRIs) are widely used, especially in alleviating psychological symptoms. Non-pharmacological interventions include aerobic exercise, cognitive behavioral therapy, mindfulness-based approaches, diet and lifestyle changes. Dietary restriction of caffeine, sugar, and salt consumption has been reported to reduce PMS symptoms.
The trend towards complementary therapies is increasing due to the lower side effect profile compared to traditional pharmacological treatments. Various herbal agents such as Vitex agnus-castus (chaste tree), Hypericum perforatum (St John's wort), evening primrose oil, and traditional herbal formulations have been studied in the literature. Vitex agnus-castus was found to be effective in relieving PMS symptoms by regulating hormonal balance. The antidepressant effects of yellow cantharone have been evaluated, but findings on its efficacy are inconsistent. Evening primrose oil shows particularly favorable effects on cyclic mastalgia. Lavender tea has the potential to alleviate depression, anxiety, and mood swings, but there are no clinical studies evaluating the effect of lavender tea on menstrual bleeding. A randomized controlled trial showed that abdominal massage with lavender oil reduced the severity of menstrual pain. However, further research examining the effects of lavender tea specifically on the menstrual process is needed.
- Conditions
- Premenstrual Syndrome, Anxiety, Depression, Stress, Pain Measurement, Complementary Medicine
- Being tested
- Lavender herbal tea
- Keywords
- premenstrual syndrome, anxiety, depression, stress, pain measurement, lavender, complementary medicine
- Medical subject headings
- Premenstrual Syndrome, Anxiety Disorders, Depression, Hemorrhage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lavender herbal teaOther
The participant will receive 36 lavender tea bags containing 2 grams of lavender tea originating from Turkey. The participant will be advised to use 2 grams of lavender herb brewed in 300 mL of hot water in the morning and evening for 9 days during 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation).
| Study group | Role | What they receive |
|---|---|---|
| Experimental group (lavender herbal tea) | Experimental | Each participant will receive 36 bags of 2 grams of lavender tea of Turkish origin. The intervention group will be advised to use 2 grams of lavender tea brewed in 300 mL of hot water in the morning and evening for 9 days during 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). Participants will be advised to take some time and inhale the scent before drinking the herbal tea. Receives: Other: Lavender herbal tea |
| Control group (wait-list) | No intervention | The control group will not receive any intervention for 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Premenstrual Syndrome Scale
Measured: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Secondary outcomes (4)
Visual Analogue Scale (VAS)
Measured: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Number of pads
Measured: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Premenstrual Syndrome Specific Quality of Life Scale
Measured: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Depression Anxiety Stress-21 Scale
Measured: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2026
- Study start9 Jul 2025
- Primary completion9 Jul 2025
- Study completion18 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Premenstrual SyndromeStudies of the same condition, open and under way.
- More trials run by Sakarya UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Control Group: No intervention will be applied to the participants in this group. Experimental Group: Participants in this group will consume 2 grams of lavender tea twice a day (morning and evening) for two menstrual cycles, starting 5 days before the estimated onset of menstruation in each cycle and continuing until 4 days after the onset of menstruation, for a total of 9 days.
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sakarya University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07737366
- Sponsor's protocol ID
- 14-3-2025-SK
- Status last verified
- Oct 2026
- First submitted
- 27 Jul 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Babajani, S., Asgari, K., Orayzi, H., & Ghasemi, N. (2017). Effectiveness of cognitive-behavioral therapy on premenstrual syndrome through compliance to treatment in an iranian sample. Zahedan Journal of Research in Medical Sciences, 19(6). https://doi.org/10.5812/zjrms.12537
Makvandi S, Mirzaiinajmabadi K, Tehranian N, Esmily H, Mirteimoori M. The Effect of Normal Physiologic Childbirth on Labor Pain Relief: an Interventional Study in Mother-Friendly Hospitals. Maedica (Bucur). 2018 Dec;13(4):286-293. doi: 10.26574/maedica.2018.13.4.286. Greek, Modern.
PubMed 30774727Savitri, R. and Hardyanti, O. (2019). The effectiveness of lavender aromatherapy in reducing the level of dysmenorrhea in adolescent girls. Journal of Maternity Care and Reproductive Health, 2(3). https://doi.org/10.36780/jmcrh.v2i3.95
Hashim, S., Elsayed, H., & Wasel, S. (2016). The effect of cinnamon on physical symptoms of premenstrual syndrome among adolescent girls. Mansoura Nursing Journal, 3(2), 83-96. https://doi.org/10.21608/mnj.2016.149415
Sener Cetin N, Solt Kirca A. The Effect of a Mindfulness-Based Stress Reduction Program on Premenstrual Symptoms: A Randomized Controlled Trial. J Midwifery Womens Health. 2023 Sep-Oct;68(5):604-610. doi: 10.1111/jmwh.13530. Epub 2023 Jun 19.
PubMed 37335817Mohebbi Dehnavi Z, Jafarnejad F, Sadeghi Goghary S. The effect of 8 weeks aerobic exercise on severity of physical symptoms of premenstrual syndrome: a clinical trial study. BMC Womens Health. 2018 May 31;18(1):80. doi: 10.1186/s12905-018-0565-5.
PubMed 29855308Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol. 2011 Mar;32(1):42-51. doi: 10.3109/0167482X.2010.538102. Epub 2010 Dec 21.
PubMed 21171936Rossignol AM, Bonnlander H. Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome. Am J Public Health. 1990 Sep;80(9):1106-10. doi: 10.2105/ajph.80.9.1106.
PubMed 2382749Takeda T. Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder. J Obstet Gynaecol Res. 2023 Feb;49(2):510-518. doi: 10.1111/jog.15484. Epub 2022 Nov 1.
PubMed 36317488Chumpalova P, Iakimova R, Stoimenova-Popova M, Aptalidis D, Pandova M, Stoyanova M, Fountoulakis KN. Prevalence and clinical picture of premenstrual syndrome in females from Bulgaria. Ann Gen Psychiatry. 2020 Jan 15;19:3. doi: 10.1186/s12991-019-0255-1. eCollection 2020.
PubMed 31969927
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Psychological and Physiological Effects of Lavender Herbal Tea in Women With Premenstrual Syndrome: a Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT07737366
- Acronym / sponsor ID
- 14-3-2025-SK
- Conditions
- Premenstrual Syndrome, Anxiety, Depression, Stress, Pain Measurement, Complementary Medicine
- Keywords
- premenstrual syndrome, anxiety, depression, stress, pain measurement, lavender, complementary medicine
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Sakarya UniversityUniversity, hospital or other
- Study start
- 9 Jul 2025 (actual)
- Primary completion
- 9 Jul 2025 (actual)
- Study completion
- 18 Oct 2025 (actual)
- First posted
- 30 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Premenstrual syndrome (PMS) is a common but complex condition defined as a combination of emotional, psychological, and physical symptoms that occur during the luteal phase of the menstrual cycle, usually between 2 and 14 days before the onset of menstruation, and that diminish with menstruation. Epidemiological studies have reported that 80-90% of women experience premenstrual syndrome symptoms, with approximately 20-40% reported to affect daily functioning and relationships. Symptoms associated with PMS include irritability, mood swings, anxiety, depression, bloating, breast tenderness, and headaches. Pharmacological treatments such as selective serotonin reuptake inhibitors (SSRIs) and non-pharmacological methods such as dietary changes, exercise, and cognitive behavioral therapy are used in the management of PMS symptoms. Complementary herbal therapies are gaining increasing interest among individuals who want to avoid the side effects of traditional pharmacological agents. Various agents such as Vitex agnus-castus (chaste tree), Hypericum perforatum (St John's wort), evening primrose oil, and conventional herbal formulations have been studied in the literature. Vitex agnus-castus was found to be effective in relieving PMS symptoms by regulating hormonal balance. The antidepressant effects of yellow cantharone have been evaluated, but findings on its efficacy are inconsistent. Evening primrose oil shows particularly favorable effects on cyclic mastalgia. Lavender tea is known to reduce depression, anxiety, and mood swings. There are no clinical studies evaluating the effect of lavender tea on menstrual bleeding. A randomized controlled trial has shown that abdominal massage with lavender oil reduces the severity of menstrual pain. In this context, it may be a potential complementary herbal treatment to relieve PMS symptoms. Therefore, women with PMS will be divided into two groups. The intervention group will use 2 grams of lavender tea 2 times a day, morning and evening, for 9 days during 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). The control group will create a waiting list. The study data will be provided by 'Personal Information Form', 'Premenstrual Syndrome Scale', 'Depression Anxiety Stress-21 Scale', 'Premenstrual Syndrome Specific Quality of Life Scale', Visual Analogue Scale (VAS), and pad follow-up to monitor bleeding. SPSS 25.0 software will be used to analyze the data obtained from the study. Although the effects of lavender tea on PMS are promising, more clinical studies are needed to confirm its effectiveness. With this study, the need for clinical studies on the effectiveness of lavender tea will be met and a natural and complementary treatment method that can alleviate PMS symptoms will be tested.
Detailed description
Premenstrual syndrome (PMS) is a clinical picture characterized by physical, psychological, and behavioral symptoms that occur during the luteal phase of the menstrual cycle, starting approximately one week before menstruation and decreasing with menstruation. The prevalence of PMS is quite high and it is reported that 50-90% of women experience at least one PMS symptom during the reproductive age. Physical symptoms of PMS include breast tenderness and bloating, headaches, muscle and joint pain, fatigue, appetite changes, sleep disturbances, and skin problems. Psychological symptoms include irritability, outbursts of anger, hypersensitivity, crying spells, difficulty focusing, and social isolation. Behavioral symptoms include overeating, increased alcohol and caffeine consumption, sleep irregularity, and decreased physical activity.
Pharmacological, non-pharmacological, and complementary approaches are applied in the management of PMS symptoms. Within the scope of pharmacological treatment, Selective Serotonin Reuptake Inhibitors (SSRIs) are widely used, especially in alleviating psychological symptoms. Non-pharmacological interventions include aerobic exercise, cognitive behavioral therapy, mindfulness-based approaches, diet and lifestyle changes. Dietary restriction of caffeine, sugar, and salt consumption has been reported to reduce PMS symptoms.
The trend towards complementary therapies is increasing due to the lower side effect profile compared to traditional pharmacological treatments. Various herbal agents such as Vitex agnus-castus (chaste tree), Hypericum perforatum (St John's wort), evening primrose oil, and traditional herbal formulations have been studied in the literature. Vitex agnus-castus was found to be effective in relieving PMS symptoms by regulating hormonal balance. The antidepressant effects of yellow cantharone have been evaluated, but findings on its efficacy are inconsistent. Evening primrose oil shows particularly favorable effects on cyclic mastalgia. Lavender tea has the potential to alleviate depression, anxiety, and mood swings, but there are no clinical studies evaluating the effect of lavender tea on menstrual bleeding. A randomized controlled trial showed that abdominal massage with lavender oil reduced the severity of menstrual pain. However, further research examining the effects of lavender tea specifically on the menstrual process is needed.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Control Group: No intervention will be applied to the participants in this group. Experimental Group: Participants in this group will consume 2 grams of lavender tea twice a day (morning and evening) for two menstrual cycles, starting 5 days before the estimated onset of menstruation in each cycle and continuing until 4 days after the onset of menstruation, for a total of 9 days.
| Arm | Type | Receives |
|---|---|---|
| Experimental group (lavender herbal tea) | Experimental | Other: Lavender herbal teaEach participant will receive 36 bags of 2 grams of lavender tea of Turkish origin. The intervention group will be advised to use 2 grams of lavender tea brewed in 300 mL of hot water in the morning and evening for 9 days during 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). Participants will be advised to take some time and inhale the scent before drinking the herbal tea. |
| Control group (wait-list) | No intervention | –The control group will not receive any intervention for 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- No history of acute or chronic illness, Meeting the diagnostic criteria for PMS specified by ACOG, Over 18 years of age, No psychiatric distress and no treatment for psychiatric distress in the last 3 months, No (current or past) participation in psychotherapy for premenstrual symptoms, Not pregnant, Gynecological diseases (hysterectomy, oophorectomy, gynecological cancer, polycystic ovary syndrome, endometriosis, infertility) are among the inclusion criteria.
Key exclusion criteria (1 listed)
- Allergy to any herbal tea, food or medicine, Psychiatric illness or chronic illness, Use of psychiatric medication (such as anxiolytics and antidepressants), Regular medication use (such as antihypertensive, antidiabetic), Regular use of herbal teas or complementary medicines, Failure to meet the diagnostic criteria for PMS specified by ACOG, No regular menstruation in the last 3 months, Use of oral contraceptives during the last 3 months, Use of analgesics during menstruation while participating in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lavender herbal teaThe participant will receive 36 lavender tea bags containing 2 grams of lavender tea originating from Turkey. The participant will be advised to use 2 grams of lavender herb brewed in 300 mL of hot water in the morning and evening for 9 days during 2 menstrual cycles (5 days before and 4 days after the estimated onset of menstruation). | Other | Experimental group (lavender herbal tea) |
Primary outcome
Premenstrual Syndrome Scale
Time frame: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
4 secondary outcomes
Visual Analogue Scale (VAS)
Time frame: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Number of pads
Time frame: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Premenstrual Syndrome Specific Quality of Life Scale
Time frame: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Depression Anxiety Stress-21 Scale
Time frame: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
- BackgroundBabajani, S., Asgari, K., Orayzi, H., & Ghasemi, N. (2017). Effectiveness of cognitive-behavioral therapy on premenstrual syndrome through compliance to treatment in an iranian sample. Zahedan Journal of Research in Medical Sciences, 19(6). https://doi.org/10.5812/zjrms.12537
- Results publication: PubMed 30774727Makvandi S, Mirzaiinajmabadi K, Tehranian N, Esmily H, Mirteimoori M. The Effect of Normal Physiologic Childbirth on Labor Pain Relief: an Interventional Study in Mother-Friendly Hospitals. Maedica (Bucur). 2018 Dec;13(4):286-293. doi: 10.26574/maedica.2018.13.4.286. Greek, Modern.
- Results publicationSavitri, R. and Hardyanti, O. (2019). The effectiveness of lavender aromatherapy in reducing the level of dysmenorrhea in adolescent girls. Journal of Maternity Care and Reproductive Health, 2(3). https://doi.org/10.36780/jmcrh.v2i3.95
- Results publicationHashim, S., Elsayed, H., & Wasel, S. (2016). The effect of cinnamon on physical symptoms of premenstrual syndrome among adolescent girls. Mansoura Nursing Journal, 3(2), 83-96. https://doi.org/10.21608/mnj.2016.149415
- Results publication: PubMed 37335817Sener Cetin N, Solt Kirca A. The Effect of a Mindfulness-Based Stress Reduction Program on Premenstrual Symptoms: A Randomized Controlled Trial. J Midwifery Womens Health. 2023 Sep-Oct;68(5):604-610. doi: 10.1111/jmwh.13530. Epub 2023 Jun 19.
- Results publication: PubMed 29855308Mohebbi Dehnavi Z, Jafarnejad F, Sadeghi Goghary S. The effect of 8 weeks aerobic exercise on severity of physical symptoms of premenstrual syndrome: a clinical trial study. BMC Womens Health. 2018 May 31;18(1):80. doi: 10.1186/s12905-018-0565-5.
- Results publication: PubMed 21171936Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol. 2011 Mar;32(1):42-51. doi: 10.3109/0167482X.2010.538102. Epub 2010 Dec 21.
- Results publication: PubMed 2382749Rossignol AM, Bonnlander H. Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome. Am J Public Health. 1990 Sep;80(9):1106-10. doi: 10.2105/ajph.80.9.1106.
- Results publication: PubMed 36317488Takeda T. Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder. J Obstet Gynaecol Res. 2023 Feb;49(2):510-518. doi: 10.1111/jog.15484. Epub 2022 Nov 1.
- Results publication: PubMed 31969927Chumpalova P, Iakimova R, Stoimenova-Popova M, Aptalidis D, Pandova M, Stoyanova M, Fountoulakis KN. Prevalence and clinical picture of premenstrual syndrome in females from Bulgaria. Ann Gen Psychiatry. 2020 Jan 15;19:3. doi: 10.1186/s12991-019-0255-1. eCollection 2020.
- Individual participant dataSharing planned: No
Related trials for Premenstrual Syndrome
Not yet recruitingPhase 1
MLS101 Study in PMDD
Premenstrual Dysphoric Disorder ( PMDD), PMDD
Not yet recruiting
Integrated Core Stability Exercises and Yoga Program on Premenstrual Syndrome
Premenstrual Syndrome
Enrolling by invitation
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Perimenopause, PMDD
Recruiting
A Clinical Trial to Evaluate the Effects of the Kaia Relief - Cycle System on Premenstrual Symptom Severity, Menstrual Discomfort, and Overall Well-Being in Premenopausal Women.
Premenstrual Syndrome, Menstrual Discomfort
RecruitingObservational study
Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health
Premenstrual Dysphoric Disorder (PMDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Lavender herbal tea in people with Premenstrual Syndrome and Anxiety, run by Sakarya University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Premenstrual Syndrome Scale (time frame: 1. within 24 hours on the 4th day of menstruation (after the first 9 days of lavender tea use) 2. within 24 hours on the 4th day of menstruation (after the second 9 days of lavender tea use)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07737366, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.